Lemelson Capital Management

Lemelson Capital Management is a private investment management firm that focuses on deep value and activist investment strategies. Founded by Rev. Emmanuel Lemelson, the firm serves as the investment manager for the Amvona Fund. Although it is a financial institution rather than a laboratory-based entity, it has a significant history of involvement in the life sciences and healthcare sectors through its activist research and short positions. The firm gained widespread attention for its critical analysis and short-selling of companies like Ligand Pharmaceuticals and Prothena. Its investment approach is characterized by high-conviction, concentrated positions based on fundamental analysis of corporate balance sheets and intellectual property.